DARIOHEALTH CORP
DARIOHEALTH CORP logo
DRIO

DARIOHEALTH CORP (DRIO)

$4.891.03%

Market is closed
– opens on 8 PM, 05 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$4.77
Day's Range
$4.995
$3.66
52-Week Range
$15.45
1 month return21.95%
3 month return18.69%
1 year return66.28%
5 year return83.48%

Company Information

DarioHealth Corp. is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, the Company empowers individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Its cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease.
OrganizationDARIOHEALTH CORP
Employees200
CEOMr. Erez Raphael
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
85%
Buy
14%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for DARIOHEALTH CORP(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 167.28%

Current

$4.89

Target

$13.07

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
6
12
12
Hold
1
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
113.9M
Book Value
$3.82
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.47
PEG Ratio
0.0
Wall Street Target Price
13.07

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
1.3
Enterprise Value
84.1M
Enterprise Value/Revenue
3.13
Enterprise Value/Ebitda
-1.26

Technicals

Beta
1.17
50 Day MA
4.59
200 Day MA
5.61

Institutional Holdings

Nantahala Capital Management, LLC

7.43%

Clal Insurance Enterprises Holdings Ltd

6.67%

Phoenix Holdings Ltd

5.76%

Appian WAY Asset Management

3.92%

Millennium Management LLC

2.1%

Mccormack Advisors International

1.5%

Discover more

Frequently Asked Questions

What is DARIOHEALTH CORP share price today?

Can Indians buy DARIOHEALTH CORP shares?

How can I buy DARIOHEALTH CORP shares from India?

Can Fractional shares of DARIOHEALTH CORP be purchased?

What are the documents required to start investing in DARIOHEALTH CORP stocks?

What are today’s High and Low prices of DARIOHEALTH CORP?

What are today’s traded volumes of DARIOHEALTH CORP?

What is today’s market capitalisation of DARIOHEALTH CORP?

What is the 52 Week High and Low Range of DARIOHEALTH CORP?

How much percentage DARIOHEALTH CORP is down from its 52 Week High?

How much percentage DARIOHEALTH CORP is up from its 52 Week low?

What are the historical returns of DARIOHEALTH CORP?

Who is the Chief Executive Officer (CEO) of DARIOHEALTH CORP?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*